Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dyck

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Pain|June 8, 2013
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensusMiroslav Misha Backonja, Nadine Attal, Ralf Baron, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Nature Genetics|May 3, 2011
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossChristopher J Klein, Maria-Victoria Botuyan, Yanhong Wu, et al.
Brain : a Journal of Neurology|February 14, 2015
Defects of mutant DNMT1 are linked to a spectrum of neurological disordersJonathan Baets, Xiaohui Duan, Yanhong Wu, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
The New England Journal of Medicine|July 5, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, et al.
Muscle & Nerve|January 8, 2017
Assessing mNIS+7<sub>Ionis</sub> and international neurologists' proficiency in a familial amyloidotic polyneuropathy trialPeter J Dyck, John C Kincaid, P James B Dyck, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
Journal of Neurology|July 31, 2022
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateThomas H Brannagan, Teresa Coelho, Annabel K Wang, et al.
Neurology and Therapy|February 27, 2021
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L<sub>Rx</sub> (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid PolyneuropathyTeresa Coelho, Yukio Ando, Merrill D Benson, et al.
Pain|June 8, 2013
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensusMiroslav Misha Backonja, Nadine Attal, Ralf Baron, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Nature Genetics|May 3, 2011
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossChristopher J Klein, Maria-Victoria Botuyan, Yanhong Wu, et al.
Brain : a Journal of Neurology|February 14, 2015
Defects of mutant DNMT1 are linked to a spectrum of neurological disordersJonathan Baets, Xiaohui Duan, Yanhong Wu, et al.
The New England Journal of Medicine|July 5, 2018
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D Benson, Márcia Waddington-Cruz, John L Berk, et al.
The New England Journal of Medicine|July 5, 2018
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Alejandra Gonzalez-Duarte, William D O'Riordan, et al.
Muscle & Nerve|January 8, 2017
Assessing mNIS+7<sub>Ionis</sub> and international neurologists' proficiency in a familial amyloidotic polyneuropathy trialPeter J Dyck, John C Kincaid, P James B Dyck, et al.
Pageof 55